Clinical Trial Update: Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating selumetinib with pemetrexed and platinum in advanced/metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• Platinum-based chemotherapy (platinum-based chemotherapy)
• Selumetinib (selumetinib)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-06-22